Responsible governance

Commitment to
Good Governance

Our commitment to excellence is linked to observing and complying with the law and regulations applicable to us as a listed pharmaceutical company. At ROVI, we have furnished ourselves with policies and procedures that reflect our ethics in our work and in our relations with our stakeholders. Here, you will find information that will give you a greater insight into how we work.

Our commitment to the SDGs

Compromiso con los ODS

Key indicators


42,85% Independent


42,85% Female

Approval of ESG Master Plan 2023-2025

Approval of
ESG Master Plan 2023-2025
by Board of Directors

Remuneración de los  miembros

Compensation of
Board members
linked to attainment of ESG objectives

Member of the United Nations Global Compact

As a member of the United Nations Global Compact, ROVI supports, by adopting and transmitting them, the incorporation of the principles of said Compact, as well as other international instruments, such as the Core Conventions of the International Labour Organisation (ILO) related to respect for freedom of association and the right to collective bargaining.

Our performance

Consejo de administración

Board of Directors

Governance body responsible for the oversight and control of the company. Likewise, it is responsible for the Financial and Non-financial Risk Control Policy and for the periodic monitoring of the internal information and control systems.

See more



We consider that risk control and management contribute to achieving greater efficiency and efficacy in the company's operations and attaining the corporate goals.

See more



We strive to carry out our activities while complying with the principles of business ethics.

See more

Commitment to transparency

Commitment to transparency

Society requires the pharmaceutical industry to provide it with the best medicines possible. To reach this goal, it is necessary to invest in both Research and Development and training, with the need for close collaboration with healthcare professionals and organisations and patients’ organisations. This valuable exchange of knowledge and experience allows the most innovative treatments to be provided, thus giving the patients hope and enhancing their quality of life.

See more